6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Complete Histological Regression of Kaposi's Sarcoma Following Treatment with Protease Inhibitors Despite Persistence of HHV-8 in Lesions

Page 614 | Published online: 08 Jul 2009

References

  • Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 226: 1965–9.
  • Gao S-J, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-like latent nuclear antigens before the development of Kaposi’s sarcoma. N Engl J Med 1996; 335: 233–41.
  • Boshoff C, Talbot S, Whitby D, et al. AIDS associated tumors and HHV-8. J AIDS Human Retrovirology 1997; 14 (4): A18.
  • Morefeldt L, Torssander J. Long-term remission of Kaposi’s sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994; 26: 749–52.
  • Cordero E, López-Córtés LF, Viciana P, Alarcón A, Pachón J. Foscarnet and AIDS associated Kaposi’s sarcoma. AIDS 1997; 11: 1787–8.
  • Murphy M, Armstrong D, Sepkowitz KA, Ahkami RN, Myskowski PL. Regression of AIDS-related Kaposi’s sarcoma following treatment with an HIV-1 protease inhibitor. AIDS 1997; 11: 261–2.
  • Blum L, Pellet C, Agbalika F, et al. Complete remission of AIDS-related Kaposi’s sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS 1997; 11: 1653–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.